These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2798547)

  • 41. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine.
    Jeste DV; Perlow MJ; Wyatt RJ; Stoff DM
    Commun Psychopharmacol; 1979; 3(1):41-7. PubMed ID: 38031
    [No Abstract]   [Full Text] [Related]  

  • 43. Subchronic morphine increases amphetamine-induced potentiation of brain stimulation reward: reversal by DNQX.
    Bespalov AYu ; Zvartau EE
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):89-93. PubMed ID: 7549460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gender-related differences exist in cortical [3H]nisoxetine binding and are not affected by prenatal morphine exposure.
    Vathy I; Sokol J; Etgen AM
    Neuroscience; 1997 Jan; 76(2):331-4. PubMed ID: 9015318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopaminergic brain reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine- and cocaine-regulated phosphoproteins.
    Beitner-Johnson D; Guitart X; Nestler EJ
    Brain Res; 1991 Oct; 561(1):147-50. PubMed ID: 1686743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naloxone attenuation of the effect of cocaine on rewarding brain stimulation.
    Bain GT; Kornetsky C
    Life Sci; 1987 Mar; 40(11):1119-25. PubMed ID: 3493402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacologic properties and mechanism of action of amfonelic acid.
    Aceto MD; Botton I; Martin R; Levitt M; Bentley HC; Speight PT
    Eur J Pharmacol; 1970; 10(3):344-54. PubMed ID: 4393073
    [No Abstract]   [Full Text] [Related]  

  • 48. Nisoxetine infusion into the olfactory bulb enhances the capacity for male rats to identify conspecifics.
    Shang Y; Dluzen DE
    Neuroscience; 2001; 104(4):957-64. PubMed ID: 11457583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors.
    Harrison AA; Markou A
    J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of nicotine on the threshold for rewarding brain stimulation in rats.
    Huston-Lyons D; Kornetsky C
    Pharmacol Biochem Behav; 1992 Apr; 41(4):755-9. PubMed ID: 1594644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice.
    Gilliss B; Malanga CJ; Pieper JO; Carlezon WA
    Psychopharmacology (Berl); 2002 Sep; 163(2):238-48. PubMed ID: 12202971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentiation of morphine analgesia by d-amphetamine.
    Sasson S; Unterwald EM; Kornetsky C
    Psychopharmacology (Berl); 1986; 90(2):163-5. PubMed ID: 3097695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using a rate-frequency curve method to assess the rewarding properties of morphine in the intracranial self-stimulation paradigm in rats.
    O'Neill KS; Todtenkopf MS
    J Neurosci Methods; 2010 May; 189(1):75-9. PubMed ID: 20304007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic morphine fails to enhance the reward value of prefrontal cortex self-stimulation.
    Corbett D
    Pharmacol Biochem Behav; 1992 Jul; 42(3):451-5. PubMed ID: 1409778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function".
    Nestler EJ
    Brain Res; 2016 Aug; 1645():71-4. PubMed ID: 26740398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of nalbuphine alone and in combination with tripelennamine on rewarding brain stimulation thresholds in the rat.
    Unterwald EM; Kornetsky C
    Pharmacol Biochem Behav; 1986 Sep; 25(3):629-32. PubMed ID: 3774829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The basolateral complex of the amygdala mediates the modulation of intracranial self-stimulation threshold by drug-associated cues.
    Hayes RJ; Gardner EL
    Eur J Neurosci; 2004 Jul; 20(1):273-80. PubMed ID: 15245499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine.
    Zarepour L; Fatahi Z; Sarihi A; Haghparast A
    Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of cocaine and GBR-12909 on brain stimulation reward.
    Maldonado-Irizarry CS; Stellar JR; Kelley AE
    Pharmacol Biochem Behav; 1994 Aug; 48(4):915-20. PubMed ID: 7972296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.